Skip to main content
Clinical Trials/ChiCTR-ORC-16008872
ChiCTR-ORC-16008872Active, not recruiting回顾性研究

静脉输注丙种球蛋白免疫调节治疗早产儿脓毒症的研究

国家自然科学基金和自筹1 site in 1 country60 target enrollmentStarted: July 31, 2016Last updated:

Trial Snapshot

Phase
回顾性研究
Status
Active, not recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Foxp3 标志

Study Overview

Brief Summary

观察大剂量静脉输注丙种球蛋白对近足月早产儿免疫功能的影响,进而为临床应用提供依据。

Study Design

Study Type
观察性研究
Primary Purpose
队列研究

Eligibility Criteria

Ages
0 to 0 (—)
Sex
All

Inclusion Criteria

  • 胎龄不满 37 周早产儿,有胎膜早破等宫内感染史需入住 NICU 的早产儿。

Exclusion Criteria

  • Premature babies with congenital malformations, autoimmune diseases, and those whose date of birth were missing or uncertain, guardian of the premature infants were unwilling to participate in the study.

Arms & Interventions

IVIG 干预

IVIG 输注

Outcomes

Primary Outcomes

Foxp3 标志

Time Frame: 生后第一天及第四天

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
国家自然科学基金和自筹

Study Sites (1)

Loading locations...

Similar Trials